{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:12:26Z","timestamp":1788487946427,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05006-x","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:46:21Z","timestamp":1782139581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Curative treatment is feasible for recurrent hepatocellular carcinoma regardless of recurrence pattern after hepatitis C virus eradication with interferon-free direct-acting antiviral therapy"],"prefix":"10.1186","volume":"26","author":[{"given":"Satoru","family":"Hagiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Omaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Okai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoriaki","family":"Komeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuomi","family":"Ueshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Takita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Chishina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoshi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"5006_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14218\/JCTH.2017.00067","volume":"6","author":"P Axley","year":"2018","unstructured":"Axley P, Ahmed Z, Ravi S, Singal AK. Hepatitis C virus and hepatocellular carcinoma: A narrative review. J Clin Transl Hepatol. 2018;6:1\u20136. https:\/\/doi.org\/10.14218\/JCTH.2017.00067.","journal-title":"J Clin Transl Hepatol"},{"key":"5006_CR2","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/JHC.S556306","volume":"25","author":"WL Luo","year":"2025","unstructured":"Luo WL, Wang QB, Li YK, Liang YB, Li J, Chen XM, et al. Impact of middle hepatic vein resection during hemihepatectomy on surgical outcomes and long-term prognosis in hepatocellular carcinoma: a retrospective study. J Hepatocell Carcinoma. 2025;25:2681\u201392. https:\/\/doi.org\/10.2147\/JHC.S556306.","journal-title":"J Hepatocell Carcinoma"},{"key":"5006_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/jvh.12422","volume":"22","author":"JA Gutierrez","year":"2015","unstructured":"Gutierrez JA, Lawitz EJ, Poordad F. Interferon-free, direct-acting antiviral therapy for chronic hepatitis C. J Viral Hepat. 2015;22:861\u201370. https:\/\/doi.org\/10.1111\/jvh.12422.","journal-title":"J Viral Hepat"},{"key":"5006_CR4","doi-asserted-by":"publisher","unstructured":"Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology. 2017;153:996\u20131005.e1. https:\/\/doi.org\/10.1053\/j.gastro.2017.06.012.","DOI":"10.1053\/j.gastro.2017.06.012"},{"key":"5006_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/jgh.15659","volume":"37","author":"E Ogawa","year":"2022","unstructured":"Ogawa E, Nakamuta M, Furusyo N, Kajiwara E, Dohmen K, Kawano A, et al. Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct-acting antivirals. J Gastroenterol Hepatol. 2022;37:190\u20139. https:\/\/doi.org\/10.1111\/jgh.15659.","journal-title":"J Gastroenterol Hepatol"},{"key":"5006_CR6","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1007\/s10620-019-05641-3","volume":"64","author":"WY Zou","year":"2019","unstructured":"Zou WY, Choi K, Kramer JR, Yu X, Cao Y, El-Serag HB, et al. Risk of hepatocellular cancer recurrence in hepatitis C virus+ patients treated with direct-acting antiviral agents. Dig Dis Sci. 2019;64:3328\u201336. https:\/\/doi.org\/10.1007\/s10620-019-05641-3.","journal-title":"Dig Dis Sci"},{"key":"5006_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5009\/gnl20151","volume":"15","author":"YH Ahn","year":"2021","unstructured":"Ahn YH, Lee H, Kim DY, Lee HW, Yu SJ, Cho YY, et al. Independent risk factors for hepatocellular carcinoma recurrence after direct-acting antiviral therapy in patients with chronic hepatitis C. Gut Liver. 2021;15:410\u20139. https:\/\/doi.org\/10.5009\/gnl20151.","journal-title":"Gut Liver"},{"key":"5006_CR8","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","volume":"65","author":"M Reig","year":"2016","unstructured":"Reig M, Mari\u00f1o Z, Perell\u00f3 C, I\u00f1arrairaegui M, Ribeiro A, Lens S, et al. Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy. J Hepatol. 2016;65:719\u201326. https:\/\/doi.org\/10.1016\/j.jhep.2016.04.008.","journal-title":"J Hepatol"},{"key":"5006_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","volume":"65","author":"F Conti","year":"2016","unstructured":"Conti F, Buonfiglioli F, Scuteri A, Crespi C, Bolondi L, Caraceni P, et al. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol. 2016;65:727\u201333. https:\/\/doi.org\/10.1016\/j.jhep.2016.06.015.","journal-title":"J Hepatol"},{"key":"5006_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jhep.2016.06.023","volume":"65","author":"JD Yang","year":"2016","unstructured":"Yang JD, Aqel BA, Pungpapong S, Gores GJ, Roberts LR, Leise MD. Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma. J Hepatol. 2016;65:859\u201360. https:\/\/doi.org\/10.1016\/j.jhep.2016.06.023.","journal-title":"J Hepatol"},{"key":"5006_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jhep.2016.04.033","volume":"65","author":"C Camm\u00e0","year":"2016","unstructured":"Camm\u00e0 C, Cabibbo G, Crax\u00ec A. Direct antiviral agents and risk for HCC early recurrence: much ado about nothing. J Hepatol. 2016;65:861\u20132. https:\/\/doi.org\/10.1016\/j.jhep.2016.04.033.","journal-title":"J Hepatol"},{"key":"5006_CR12","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.3748\/wjg.v22.i16.4238","volume":"22","author":"BES Behairy","year":"2016","unstructured":"Behairy BES, Sira MM, Zalata KR, Salama ESE, Abd-Allah MA. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: does etiology matter? World J Gastroenterol. 2016;22:4238\u201349. https:\/\/doi.org\/10.3748\/wjg.v22.i16.4238.","journal-title":"World J Gastroenterol"},{"key":"5006_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/apt.13821","volume":"45","author":"S Petta","year":"2017","unstructured":"Petta S, Cabibbo G, Barbara M, Attardo S, Bucci L, Farinati F, et al. Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon. Aliment Pharmacol Ther. 2017;45:160\u20138. https:\/\/doi.org\/10.1111\/apt.13821.","journal-title":"Aliment Pharmacol Ther"},{"key":"5006_CR14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/liv.13357","volume":"37","author":"G Cabibbo","year":"2017","unstructured":"Cabibbo G, Petta S, Barb\u00e0ra M, Missale G, Virdone R, Caturelli E, et al. A meta-analysis of single HCV -untreated arm of studies evaluating outcomes after curative treatments of HCV -related hepatocellular carcinoma. Liver Int. 2017;37:1157\u201366. https:\/\/doi.org\/10.1111\/liv.13357.","journal-title":"Liver Int"},{"key":"5006_CR15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jhep.2017.05.028","volume":"67","author":"H Nagata","year":"2017","unstructured":"Nagata H, Nakagawa M, Asahina Y, Sato A, Asano Y, Tsunoda T, et al. Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C. J Hepatol. 2017;67:933\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2017.05.028.","journal-title":"J Hepatol"},{"key":"5006_CR16","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1007\/s10620-017-4739-z","volume":"62","author":"K Ikeda","year":"2017","unstructured":"Ikeda K, Kawamura Y, Kobayashi M, Kominami Y, Fujiyama S, Sezaki H, et al. Direct-acting antivirals decreased tumor recurrence after initial treatment of hepatitis C virus-related hepatocellular carcinoma. Dig Dis Sci. 2017;62:2932\u201342. https:\/\/doi.org\/10.1007\/s10620-017-4739-z.","journal-title":"Dig Dis Sci"},{"key":"5006_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12876-023-03099-2","volume":"24","author":"VYS Chow","year":"2024","unstructured":"Chow VYS, Cheung WI. Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong. BMC Gastroenterol. 2024;24:49. https:\/\/doi.org\/10.1186\/s12876-023-03099-2.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"5006_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1159\/000535497","volume":"13","author":"L Lani","year":"2024","unstructured":"Lani L, Stefanini B, Trevisani F. Surveillance for hepatocellular carcinoma in patients with successfully treated viral disease of the liver: a systematic review. Liver Cancer. 2024;13(4):376\u201388. https:\/\/doi.org\/10.1159\/000535497.","journal-title":"Liver Cancer"},{"key":"5006_CR19","doi-asserted-by":"publisher","unstructured":"Li J, Liang YB, Wang QB, Luo WL, Chen XM, Lakang Y et al. Rechallenge with immune checkpoint inhibitors in patients with hepatocellular carcinoma: a narrative review. Liver Cancer. 2026. In press. https:\/\/doi.org\/10.1159\/000549355.","DOI":"10.1159\/000549355"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05006-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05006-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05006-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:18:22Z","timestamp":1788484702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05006-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5006"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05006-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9623780\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the principles of the 1964 Declaration of Helsinki and its later amendments. Ethical approval was waived by the Institutional Review Board of Kindai University because this study used fully anonymized data and did not involve any direct intervention on human participants. This study was conducted as a retrospective observational study. There was no invasiveness or intervention on participants. Information about the study was published on the institution\u2019s website, and consent was obtained through an opt-out system that guaranteed the opportunity to decline consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"541"}}